LHC Group is a medical care facilities business based in the US. LHC Group shares (LHCG) are listed on the NASDAQ and all prices are listed in US Dollars. LHC Group employs 16,000 staff and has a trailing 12-month revenue of around $2.3 billion.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| 52-week range | $0.00 - $0.00 |
|---|---|
| 50-day moving average | $163.42 |
| 200-day moving average | $163.42 |
| Wall St. target price | $173.33 |
| PE ratio | 82.8341 |
| Dividend yield | $0 (0%) |
| Earnings per share (TTM) | $2.05 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing LHC Group stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LHC Group's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
LHC Group's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 83x. In other words, LHC Group shares trade at around 83x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
LHC Group's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.8667. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into LHC Group's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
LHC Group's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $142.8 million.
The EBITDA is a measure of a LHC Group's overall financial performance and is widely used to measure a its profitability.
| Revenue TTM | $2.3 billion |
|---|---|
| Operating margin TTM | 5.24% |
| Gross profit TTM | $883.6 million |
| Return on assets TTM | 2.58% |
| Return on equity TTM | 3.57% |
| Profit margin | 1.75% |
| Book value | $52.15 |
| Market Capitalization | $5.3 billion |
TTM: trailing 12 months
We're not expecting LHC Group to pay a dividend over the next 12 months.
Over the last 12 months, LHC Group's shares have ranged in value from as little as $0 up to $0. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LHC Group's is 0.4247. This would suggest that LHC Group's shares are less volatile than average (for this exchange).
LHC Group, Inc. , a health care provider, specializes in the post-acute continuum of care primarily for Medicare beneficiaries in the United States. It operates through five segments: Home Health Services, Hospice Services, Home and Community-Based Services, Facility-Based Services, and Healthcare Innovations (HCI). The Home Health Services segment offers skilled nursing, medically oriented social services and physical, occupational, and speech therapy. The Hospice Services segment provides pain and symptom management accompanied by palliative medication, emotional and spiritual support, inpatient and respite care, homemaker services, dietary counseling, family bereavement counseling, and social worker visits. Its Home and Community-Based Services segment offers range of services, such as assistance with grooming, medication reminders, meal preparation, assistance with feeding, light housekeeping, respite care, transportation, and errand. The Facility-Based Services segment treats patients with severe medical conditions who require a high-level of care and frequent monitoring by physicians and other clinical personnel.
Steps to owning and managing MRK, with 24-hour and historical pricing before you buy.
Steps to owning and managing LLY, with 24-hour and historical pricing before you buy.
Steps to owning and managing ISRG, with 24-hour and historical pricing before you buy.
Steps to owning and managing VRTX, with 24-hour and historical pricing before you buy.
Steps to owning and managing MCK, with 24-hour and historical pricing before you buy.
Steps to owning and managing UNH, with 24-hour and historical pricing before you buy.
Steps to owning and managing AMGN, with 24-hour and historical pricing before you buy.
Steps to owning and managing ABT, with 24-hour and historical pricing before you buy.
Steps to owning and managing PFE, with 24-hour and historical pricing before you buy.
Steps to owning and managing JNJ, with 24-hour and historical pricing before you buy.